| - GRCh37:
- Chr22:38509568
- GRCh38:
- Chr22:38113561
| PLA2G6 | R532fs, R710fs, R656fs, R478fs, R484fs | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38508200
- GRCh38:
- Chr22:38112193
| PLA2G6 | Q565*, Q743*, Q797*, Q571*, Q619* | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38565433
- GRCh38:
- Chr22:38169426
| PLA2G6 | M1V | PLA2G6-associated neurodegeneration | Pathogenic (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38565307
- GRCh38:
- Chr22:38169300
| PLA2G6 | Q43* | PLA2G6-associated neurodegeneration | Pathogenic (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38541592
- GRCh38:
- Chr22:38145585
| PLA2G6 | P93H | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38536067
- GRCh38:
- Chr22:38140060
| PLA2G6 | L62P, L240P | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38528897
- GRCh38:
- Chr22:38132890
| PLA2G6 | G162R, G114R, G340R | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38525572
- GRCh38:
- Chr22:38129565
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38525550
- GRCh38:
- Chr22:38129543
| PLA2G6 | I140N, I188N, I366N | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38522376
- GRCh38:
- Chr22:38126369
| PLA2G6 | | PLA2G6-associated neurodegeneration | Pathogenic (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38519221
- GRCh38:
- Chr22:38123214
| PLA2G6 | L313R, L437R, L259R, L265R, L491R | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38519144
- GRCh38:
- Chr22:38123137
| PLA2G6 | G285C, G339C, G463C, G517C, G291C | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38516838
- GRCh38:
- Chr22:38120831
| PLA2G6 | S325L, S503L, S331L, S379L, S557L | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy | Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38519146
- GRCh38:
- Chr22:38123139
| PLA2G6 | A284V, A290V, A338V, A462V, A516V | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy, not specified
| Conflicting interpretations of pathogenicity (Mar 17, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38512193-38512196
- GRCh38:
- Chr22:38116186-38116189
| PLA2G6 | S363fs, S411fs, S357fs, S535fs, S589fs | Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration | Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38508536
- GRCh38:
- Chr22:38112529
| PLA2G6 | E519K, E573K, E697K, E525K, E751K | not provided, PLA2G6-associated neurodegeneration, Neurodegeneration with brain iron accumulation, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Jul 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38539159
- GRCh38:
- Chr22:38143152
| PLA2G6 | T10A, T188A | PLA2G6-associated neurodegeneration | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38510587
- GRCh38:
- Chr22:38114580
| PLA2G6 | | not provided, PLA2G6-associated neurodegeneration | Conflicting interpretations of pathogenicity (Aug 3, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38536118
- GRCh38:
- Chr22:38140111
| PLA2G6 | P223L, P45L | Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration, Neurodegeneration with brain iron accumulation, not provided, Neurodegeneration with brain iron accumulation 2B | Conflicting interpretations of pathogenicity (Oct 27, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38536106
- GRCh38:
- Chr22:38140099
| PLA2G6 | A49V, A227V | Neurodegeneration with brain iron accumulation, PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy
| Conflicting interpretations of pathogenicity (Oct 27, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38508248
- GRCh38:
- Chr22:38112241
| PLA2G6 | A555T, A603T, A549T, A727T, A781T | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38508538
- GRCh38:
- Chr22:38112531
| PLA2G6 | C518Y, C524Y, C572Y, C696Y, C750Y | Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38511656
- GRCh38:
- Chr22:38115649
| PLA2G6 | G406R, G412R, G460R, G584R, G638R | not provided, PLA2G6-associated neurodegeneration | Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38511594
- GRCh38:
- Chr22:38115587
| PLA2G6 | N426K, N432K, N480K, N604K, N658K | PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy
| Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38508214
- GRCh38:
- Chr22:38112207
| PLA2G6 | H560P, H566P, H614P, H738P, H792P | PLA2G6-associated neurodegeneration, not provided | Uncertain significance (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38511611
- GRCh38:
- Chr22:38115604
| PLA2G6 | G421S, G427S, G475S, G599S, G653S | not specified, Neurodegeneration with brain iron accumulation 2B, Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38512190
- GRCh38:
- Chr22:38116183
| PLA2G6 | R359W, R365W, R413W, R537W, R591W | PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy
| Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38531041
- GRCh38:
- Chr22:38135034
| PLA2G6 | D105G, D283G, D57G | not provided, PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy
| Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38512163
- GRCh38:
- Chr22:38116156
| PLA2G6 | R368W, R374W, R422W, R546W, R600W | not provided, PLA2G6-associated neurodegeneration, Neurodegeneration with brain iron accumulation
| Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38511670
- GRCh38:
- Chr22:38115663
| PLA2G6 | A401V, A407V, A455V, A579V, A633V | not provided, PLA2G6-associated neurodegeneration, Abnormality of the nervous system, not specified | Conflicting interpretations of pathogenicity (Jun 20, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38508302
- GRCh38:
- Chr22:38112295
| PLA2G6 | Q531*, Q537*, Q585*, Q709*, Q763* | PLA2G6-associated neurodegeneration, Neurodegeneration with brain iron accumulation | Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38565318
- GRCh38:
- Chr22:38169311
| PLA2G6 | R39Q | PLA2G6-associated neurodegeneration, Autosomal recessive Parkinson disease 14, Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, Infantile neuroaxonal dystrophy | Uncertain significance (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38508240
- GRCh38:
- Chr22:38112233
| PLA2G6 | W551*, W557*, W605*, W729*, W783* | PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy
| Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38508233
- GRCh38:
- Chr22:38112226
| PLA2G6 | E554K, E560K, E608K, E732K, E786K | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38508233
- Chr22:38536118
- GRCh38:
- Chr22:38112226
- Chr22:38140111
| PLA2G6, PLA2G6 | E554K, E560K, E608K, E732K, E786K, P223Q, P45Q | Infantile neuroaxonal dystrophy | Pathogenic (May 31, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr22:38528894
- GRCh38:
- Chr22:38132887
| PLA2G6 | A115T, A163T, A341T | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, not provided | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38525536
- GRCh38:
- Chr22:38129529
| PLA2G6 | V145M, V193M, V371M | Inborn genetic diseases, PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy
| Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38541551
- GRCh38:
- Chr22:38145544
| PLA2G6 | L107fs | Neurodegeneration with brain iron accumulation 2B, PLA2G6-associated neurodegeneration, not provided
| Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38536177
- GRCh38:
- Chr22:38140170
| PLA2G6 | | PLA2G6-associated neurodegeneration | Likely pathogenic (Mar 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38539273
- GRCh38:
- Chr22:38143266
| PLA2G6 | E150K | PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy
| Uncertain significance (Oct 25, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38536010
- GRCh38:
- Chr22:38140003
| PLA2G6 | A259D, A81D | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38511591
- GRCh38:
- Chr22:38115584
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Feb 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38511540
- GRCh38:
- Chr22:38115533
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38508213
- GRCh38:
- Chr22:38112206
| PLA2G6 | H560Q, H566Q, H614Q, H738Q, H792Q | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38508133
- GRCh38:
- Chr22:38112126
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38530989
- GRCh38:
- Chr22:38134982
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38530987
- GRCh38:
- Chr22:38134980
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38577755
- GRCh38:
- Chr22:38181748
| LOC112695092, PLA2G6 | | PLA2G6-associated neurodegeneration | Benign (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38507675
- GRCh38:
- Chr22:38111668
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38507653
- GRCh38:
- Chr22:38111646
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38565367
- GRCh38:
- Chr22:38169360
| PLA2G6 | R23W | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38565279
- GRCh38:
- Chr22:38169272
| PLA2G6 | N52S | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy | Uncertain significance (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38524266
- GRCh38:
- Chr22:38128259
| PLA2G6 | | Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38516908
- GRCh38:
- Chr22:38120901
| PLA2G6 | M302V, M356V, M534V, M308V, M480V | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38516894
- GRCh38:
- Chr22:38120887
| PLA2G6 | | not provided, PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy
| Conflicting interpretations of pathogenicity (May 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38507548
- GRCh38:
- Chr22:38111541
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38507496
- GRCh38:
- Chr22:38111489
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38507492
- GRCh38:
- Chr22:38111485
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38516881
- GRCh38:
- Chr22:38120874
| PLA2G6 | R311C, R317C, R543C, R365C, R489C | not provided, PLA2G6-associated neurodegeneration | Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38528959
- GRCh38:
- Chr22:38132952
| PLA2G6 | T141M, T93M, T319M | not specified, PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Oct 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38522378
- GRCh38:
- Chr22:38126371
| PLA2G6 | T298I, T422I, T244I, T250I, T476I | Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration, Autosomal recessive Parkinson disease 14, Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, not provided, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Sep 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38524438
- GRCh38:
- Chr22:38128431
| PLA2G6 | | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38536029
- GRCh38:
- Chr22:38140022
| PLA2G6 | G253S, G75S | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38519198
- GRCh38:
- Chr22:38123191
| PLA2G6 | A267T, A499T, A273T, A445T, A321T | Infantile neuroaxonal dystrophy, PLA2G6-related condition, PLA2G6-associated neurodegeneration
| Conflicting interpretations of pathogenicity (Oct 9, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38512183
- GRCh38:
- Chr22:38116176
| PLA2G6 | P415L, P539L, P593L, P367L, P361L | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38511585
- GRCh38:
- Chr22:38115578
| PLA2G6 | | Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration, not provided
| Conflicting interpretations of pathogenicity (Apr 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38529025
- GRCh38:
- Chr22:38133018
| PLA2G6 | | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy, not provided
| Conflicting interpretations of pathogenicity (Oct 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38528949
- GRCh38:
- Chr22:38132942
| PLA2G6 | | not provided, Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration, not specified | Conflicting interpretations of pathogenicity (Mar 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38525460
- GRCh38:
- Chr22:38129453
| PLA2G6 | | not provided, PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy
| Pathogenic/Likely pathogenic (Oct 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38541545
- GRCh38:
- Chr22:38145538
| PLA2G6 | H109D | Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38516918
- GRCh38:
- Chr22:38120911
| PLA2G6 | | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy | Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38528924
- GRCh38:
- Chr22:38132917
| PLA2G6 | D331N, D105N, D153N | PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy, not specified | Conflicting interpretations of pathogenicity (Feb 13, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38508314
- GRCh38:
- Chr22:38112307
| PLA2G6 | | Infantile neuroaxonal dystrophy, not provided, PLA2G6-associated neurodegeneration
| Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38565418
- GRCh38:
- Chr22:38169411
| PLA2G6 | R6C | Inborn genetic diseases, not provided, PLA2G6-associated neurodegeneration, Autosomal recessive Parkinson disease 14, Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, Infantile neuroaxonal dystrophy | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38541474
- GRCh38:
- Chr22:38145467
| PLA2G6 | | not provided, Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration
| Conflicting interpretations of pathogenicity (Aug 30, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38519161
- GRCh38:
- Chr22:38123154
| PLA2G6 | L511P, L279P, L285P, L333P, L457P | PLA2G6-associated neurodegeneration, not provided | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38522377
- GRCh38:
- Chr22:38126370
| PLA2G6 | | not provided, Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, Autosomal recessive Parkinson disease 14, PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy
| Pathogenic/Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38541572
- GRCh38:
- Chr22:38145565
| PLA2G6 | Q100* | not provided, PLA2G6-associated neurodegeneration | Likely pathogenic (Jan 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38541454
- GRCh38:
- Chr22:38145447
| PLA2G6 | R139H | not provided, Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, Autosomal recessive Parkinson disease 14, Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration
| Conflicting interpretations of pathogenicity (Jul 1, 2023) | criteria provided, conflicting interpretations |
| | | | Infantile neuroaxonal dystrophy | Likely pathogenic (Oct 3, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr22:38519097
- GRCh38:
- Chr22:38123090
| PLA2G6 | | PLA2G6-associated neurodegeneration, not provided | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38509567
- GRCh38:
- Chr22:38113560
| PLA2G6 | R656H, R710H, R532H, R484H, R478H | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy, not provided, Abnormal brain morphology | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38565225
- GRCh38:
- Chr22:38169218
| PLA2G6 | R70Q | Infantile neuroaxonal dystrophy, not provided, PLA2G6-associated neurodegeneration, Spastic ataxia | Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38511589
- GRCh38:
- Chr22:38115582
| PLA2G6 | P660R, P428R, P482R, P434R, P606R | PLA2G6-associated neurodegeneration, not provided | Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38577754
- GRCh38:
- Chr22:38181747
| LOC112695092, PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38565464
- GRCh38:
- Chr22:38169457
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38565453
- GRCh38:
- Chr22:38169446
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38565448
- GRCh38:
- Chr22:38169441
| PLA2G6 | | PLA2G6-associated neurodegeneration | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:38565343
- GRCh38:
- Chr22:38169336
| PLA2G6 | D31N | Autosomal recessive Parkinson disease 14, Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, Inborn genetic diseases, PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Sep 6, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38565333
- GRCh38:
- Chr22:38169326
| PLA2G6 | S34L | Autosomal recessive Parkinson disease 14, Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, not specified, PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Oct 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38541604
- GRCh38:
- Chr22:38145597
| PLA2G6 | S89Y | PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy
| Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38539282
- GRCh38:
- Chr22:38143275
| PLA2G6 | A147T | not specified, not provided, PLA2G6-associated neurodegeneration, Autosomal recessive Parkinson disease 14, Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation 2B, Infantile neuroaxonal dystrophy | Uncertain significance (Aug 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38539280
- GRCh38:
- Chr22:38143273
| PLA2G6 | | PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Mar 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38536013
- GRCh38:
- Chr22:38140006
| PLA2G6 | S258L, S80L | PLA2G6-associated neurodegeneration, not provided, Infantile neuroaxonal dystrophy
| Conflicting interpretations of pathogenicity (Jun 9, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38529031
- GRCh38:
- Chr22:38133024
| PLA2G6 | | Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration | Conflicting interpretations of pathogenicity (Sep 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38528925
- GRCh38:
- Chr22:38132918
| PLA2G6 | | not provided, PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy
| Benign/Likely benign (Jan 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38528920
- GRCh38:
- Chr22:38132913
| PLA2G6 | C332S, C106S, C154S | not provided, Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration
| Uncertain significance (May 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38524419
- GRCh38:
- Chr22:38128412
| PLA2G6 | I402N, I176N, I224N | not provided, PLA2G6-associated neurodegeneration, Infantile neuroaxonal dystrophy
| Uncertain significance (Aug 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:38524357
- GRCh38:
- Chr22:38128350
| PLA2G6 | A423T, A245T, A197T | PLA2G6-associated neurodegeneration, not provided, Inborn genetic diseases, Infantile neuroaxonal dystrophy | Conflicting interpretations of pathogenicity (Feb 16, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:38522391
- GRCh38:
- Chr22:38126384
| PLA2G6 | D472N, D418N, D246N, D240N, D294N | not provided, Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration
| Uncertain significance (Jun 4, 2022) | criteria provided, multiple submitters, no conflicts |